Following up on my post from the 15th after FMC dropped that awful profit warning, I promised I wouldn’t make any reckless moves until digging into the official Q3 numbers.
Over the weekend, I pulled up the 10-Q financial notes and dissected the entire earnings call transcript line by line.
My honest takeaway?
Management’s report card barely squeezed by with a passing grade. While we got preliminary answers to the three core questions I laid out earlier, a hidden red flag also popped up on the balance sheet.
Here is my raw, unfiltered breakdown as a professional accountant who looks at financial ledgers for a living.
1. Checking the Answers to My 3 Core Questions
Question 1: What was the real nature of those “Commercial Actions”?
Management’s line: They claimed this was simply a rebate adjustment for previously sold high-priced inventory, promising it “would not impact future cash obligations.”
My accountant take: I hunted through the accounting notes in the 10-Q, and frankly, the underlying accounting logic remains murky. My professional instinct tells me management is playing word games with the phrase “no cash impact.” If this was merely a structural rebate tweak, it shouldn’t hit the income statement at all. My trust in management just took another notch down.
Question 2: What is the 2027–2028 guidance for the new patented pipeline?
The projected trajectory for 2027 and 2028 actually looks pretty strong. This was one of the few genuine bright spots in the entire release.
Question 3: How fast can they trim operational costs?
The cost-cutting effects are slated to kick in by the second half of 2027. It’s middle-of-the-road—neither a big surprise nor a total disappointment.
2. The Hidden Minefield: An $800 Million DTA Valuation Allowance
Beyond my initial questions, the 10-Q revealed a detail that makes any financial manager hyper-vigilant: FMC took a massive $800 Million valuation allowance against its Deferred Tax Assets (DTA).
In plain English: The company is officially admitting they might not generate enough future taxable profit to actually use that $800M in tax credits, so they wiped it off the asset side of the balance sheet.
While multinational tax structures are complex and a DTA write-down doesn’t automatically mean core operations are dead, it sends a different picture than the one paitned by management’s rosy talk of a “strong 2027–2028 recovery.” Not a good signal.
So, why am I not dumping the stock after all these mixed signals?
Because of the sheer, absurd margin of safety in the current valuation. Even after Friday’s impressive 30% rally, the market cap sits around $1 Billion.
Look at the conservative math based on their 2028 guidance:
2028 Projected EBITDA: ~$800 Million.
Subtract interest expenses, depreciation, and taxes...
Bottom-line Net Income (Floor): You’re still conservatively looking at ~$300 Million in net profit.
Do the math: a $1B valuation on $300M in net earnings translates to a dirt-cheap 3x Forward P/E ratio. That valuation floor is simply too low to ignore.
Taking all these facts together, my action plan is crystal clear: I will NOT add a single new share, but I will NOT sell a single share either. I am holding my position firmly right where it is.
The CEO of FMC actually said something during the call that nailed it on the head:
“We clearly recognize that the only way to rebuild investor trust in FMC is to deliver results and prove it through execution.”
Exactly. Since management knows that painting rosy pictures doesn’t work anymore, it’s time to shut up and let the financial statements do the talking.
Friday’s 30% rebound was a nice start.
Disclosure: I hold a long position in FMC Corp (NYSE: FMC) at the time of writing. As a value investor, I run a concentrated portfolio and manage my own risk. However, I may buy, sell, or adjust my holdings at any time without prior notice.
Disclaimer: This article represents my personal investment journal and is for informational and educational purposes only. It is NOT financial or investment advice. I am a professional accountant sharing my own research, not your financial advisor. Always do your own homework before investing.